Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Sell
1,181
-191
-14% -$65.4K 0.08% 190
2026
Q1
$483K Buy
1,372
+100
+8% +$35.6K 0.11% 164
2025
Q4
$416K Sell
1,272
-22
-2% -$6.98K 0.1% 169
2025
Q3
$365K Buy
1,294
+74
+6% +$21.5K 0.09% 174
2025
Q2
$341K Buy
1,220
+22
+2% +$6.23K 0.09% 179
2025
Q1
$373K Buy
1,198
+19
+2% +$5.61K 0.11% 163
2024
Q4
$307K Sell
1,179
-17
-1% -$5.04K 0.09% 183
2024
Q3
$385K Sell
1,196
-99
-8% -$32.4K 0.11% 167
2024
Q2
$405K Buy
1,295
+133
+11% +$39.1K 0.12% 156
2024
Q1
$330K Buy
1,162
+48
+4% +$14K 0.1% 168
2023
Q4
$321K Buy
1,114
+329
+42% +$89.6K 0.11% 167
2023
Q3
$211K Buy
+785
New +$196K 0.08% 196

Other funds holding AMGN

Old Port Advisors's AMGN Position: Q2 2026 in Review

Old Port Advisors reduced its Amgen (AMGN) stake by 14% in Q2 2026, selling an estimated $65.4K and leaving 1,181 shares worth $428K. The position accounts for 0.08% of the portfolio, ranked #190.

Old Port Advisors first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $483K in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Old Port Advisors held 1,181 shares of Amgen worth $428K as of Q2 2026.
  • Old Port Advisors sold 191 Amgen shares in Q2 2026, an estimated $65.4K.
  • Amgen made up 0.08% of Old Port Advisors's portfolio in Q2 2026, its #190 holding.
  • Old Port Advisors first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • Old Port Advisors's Amgen position peaked at $483K in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Old Port Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.